Trial NCT02604199

View at ClinicalTrials.gov 
Org. Study IDs: Heparc-2002
Secondary IDs: 2014-004145-27

Last trial update was posted on 2019-04-16

MeSH Interventions

Entecavir Histamine Antagonists Histamine H1 Antagonists Tenofovir

MeSH Conditions

Hepatitis Hepatitis A Hepatitis B Hepatitis B, Chronic

Other Conditions


Stopping Reasons

Company decision to discontinue trial

Limitations And Caveats

The ARC-520 Injection development program was terminated early for regulatory and business reasons secondary to findings occurring in a non-clinical toxicology study. Program termination was not due to safety findings in humans.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID